Discovery and biologics · Generative design (DMTA)
Our design-make-test-analyze cycles are too slow, and suggestions without assessment do not help.
Design and assessment in one run, for faster DMTA cycles.
Who needs this in your company
Industries
- Discovery SMEs
- Software and instrument partners
What we can do
We generate new structures under your constraints, assess them in the same run and give you a prioritised list for the next synthesis.
What you get
- Prioritised proposals with assessment
- As a pilot project or co-development
Evaluated for you or done yourself
The same calculations, different ways to you. Which one fits, we work out in the intro call.
CovaSyn in your AI (MCP)
The same calculations directly in Claude, ChatGPT or your own AI.
Learn morePilot project
One question on your data, with a success criterion agreed in writing beforehand.
From EUR 1,490 net, fully creditable
Learn moreCo-development and custom models
Models and workflows on your data, developed together in milestones.
Price on request
Learn morePartners and academic
For software and instrument partners and for research.
Terms per partner, academic free on application
Learn moreEvaluation report
You send the data, we deliver the reviewed report.
From EUR 1,490 net, typically 5 working days after complete data
Learn moreJoint funded project
A joint project with public funding, we take on the computational part.
Public funding plus own contribution
Learn more
Limits of the result
- Every proposal needs synthesis and testing.
More from this area
Molecule profile, ADMET, tox screening
We lack fast, reliable profiles to pick our candidates, and we have no cheminformatics position.
Learn moreStructure and binding
We want to test binding hypotheses, but we have no modelling group.
Learn moreBiologics: developability and sequence design
Our candidates fail late on viscosity, aggregation or immunogenicity.
Learn more
Next step
Which case is on your desk right now?
30 minutes on Microsoft Teams with the CovaSyn team. If it is not a fit, we will say so.
